Oberweis Asset Management’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-77,700
Closed -$2.06M 173
2022
Q4
$2.06M Buy
77,700
+9,900
+15% +$323K 0.44% 70
2022
Q3
$1.92M Sell
67,800
-29,100
-30% -$748K 0.45% 45
2022
Q2
$2.02M Sell
96,900
-20,156
-17% -$378K 0.51% 37
2022
Q1
$2.54M Buy
117,056
+39,156
+50% +$850K 0.51% 31
2021
Q4
$2.16M Hold
77,900
0.39% 45
2021
Q3
$1.66M Sell
77,900
-8,000
-9% -$150K 0.34% 44
2021
Q2
$1.42M Sell
85,900
-24,000
-22% -$366K 0.31% 56
2021
Q1
$1.37M Buy
109,900
+46,100
+72% +$489K 0.28% 52
2020
Q4
$566K Buy
+63,800
New +$519K 0.15% 84
2017
Q2
Sell
-43,000
Closed -$617K 139
2017
Q1
$617K Buy
43,000
+13,000
+43% +$191K 0.18% 92
2016
Q4
$468K Buy
+30,000
New +$411K 0.14% 100

Other funds holding CCRN

Oberweis Asset Management's CCRN Position: Q1 2023 in Review

Oberweis Asset Management sold out of Cross Country Healthcare (CCRN) in Q1 2023, closing a stake of 77,700 shares — an estimated $2.06M sold.

Oberweis Asset Management first reported a position in CCRN in Q4 2016 and held it in 11 quarters. The position peaked at $2.54M in Q1 2022. 201 funds tracked by Wall St. Rank hold CCRN as of Q1 2023.

  • Oberweis Asset Management reported no remaining Cross Country Healthcare position as of Q1 2023 after selling out during the quarter.
  • Oberweis Asset Management sold 77,700 Cross Country Healthcare shares in Q1 2023, an estimated $2.06M.
  • Oberweis Asset Management first reported a position in Cross Country Healthcare in Q4 2016 and held it in 11 quarters.
  • Oberweis Asset Management's Cross Country Healthcare position peaked at $2.54M in Q1 2022.
  • 201 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q1 2023.

Based on Oberweis Asset Management's 13F filing for Q1 2023, filed 15 May 2023.